Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 3
1968 2
1969 3
1970 14
1971 8
1972 13
1973 7
1974 9
1975 8
1976 5
1977 7
1978 12
1979 18
1980 7
1981 2
1982 7
1983 7
1984 4
1985 6
1986 4
1987 4
1988 6
1989 4
1990 4
1991 3
1992 3
1993 4
1994 7
1995 1
1996 2
1997 2
1998 6
1999 2
2000 4
2001 3
2002 1
2003 9
2004 2
2005 4
2006 5
2007 4
2008 4
2009 5
2010 5
2011 7
2012 10
2013 15
2014 13
2015 16
2016 22
2017 14
2018 14
2019 22
2020 43
2021 43
2022 45
Text availability
Article attribute
Article type
Publication date

Search Results

461 results
Results by year
Filters applied: . Clear all
Page 1
Age-related macular degeneration.
Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY. Fleckenstein M, et al. Among authors: keenan tdl. Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2. Nat Rev Dis Primers. 2021. PMID: 33958600 Review.
The Immunology of Hormone Receptor Positive Breast Cancer.
Goldberg J, Pastorello RG, Vallius T, Davis J, Cui YX, Agudo J, Waks AG, Keenan T, McAllister SS, Tolaney SM, Mittendorf EA, Guerriero JL. Goldberg J, et al. Among authors: keenan t. Front Immunol. 2021 May 11;12:674192. doi: 10.3389/fimmu.2021.674192. eCollection 2021. Front Immunol. 2021. PMID: 34135901 Free PMC article. Review.
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer.
Keenan TE, Guerriero JL, Barroso-Sousa R, Li T, O'Meara T, Giobbie-Hurder A, Tayob N, Hu J, Severgnini M, Agudo J, Vaz-Luis I, Anderson L, Attaya V, Park J, Conway J, He MX, Reardon B, Shannon E, Wulf G, Spring LM, Jeselsohn R, Krop I, Lin NU, Partridge A, Winer EP, Mittendorf EA, Liu D, Van Allen EM, Tolaney SM. Keenan TE, et al. Nat Commun. 2021 Sep 21;12(1):5563. doi: 10.1038/s41467-021-25769-z. Nat Commun. 2021. PMID: 34548479 Free PMC article. Clinical Trial.
Reply.
Keenan TD, Agrón E, Chew EY; AREDS2 Research Group. Keenan TD, et al. Ophthalmology. 2019 May;126(5):e40-e41. doi: 10.1016/j.ophtha.2018.11.030. Ophthalmology. 2019. PMID: 31005200 No abstract available.
Reply.
Le JT, Peprah D, Agrón E, Keenan TDL, Clemons TE, Chew EY. Le JT, et al. Among authors: keenan tdl. Ophthalmology. 2022 Jun;129(6):e67-e68. doi: 10.1016/j.ophtha.2022.02.014. Epub 2022 Apr 1. Ophthalmology. 2022. PMID: 35379480 No abstract available.
Reply.
Keenan TDL, Oden NL, Agrón E, Clemons TE, Henning A, Wong WT, Chew EY. Keenan TDL, et al. Ophthalmol Retina. 2022 Apr;6(4):334-335. doi: 10.1016/j.oret.2021.12.002. Ophthalmol Retina. 2022. PMID: 35393078 No abstract available.
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial.
Tolaney SM, Barroso-Sousa R, Keenan T, Li T, Trippa L, Vaz-Luis I, Wulf G, Spring L, Sinclair NF, Andrews C, Pittenger J, Richardson ET 3rd, Dillon D, Lin NU, Overmoyer B, Partridge AH, Van Allen E, Mittendorf EA, Winer EP, Krop IE. Tolaney SM, et al. Among authors: keenan t. JAMA Oncol. 2020 Oct 1;6(10):1598-1605. doi: 10.1001/jamaoncol.2020.3524. JAMA Oncol. 2020. PMID: 32880602 Free PMC article. Clinical Trial.
461 results